SCHEMBL4412244

SCHEMBL4412244

C/C(=C\CCOC#N)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CD81 P60033 2/20 0.34
PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4412246 1.00 CD81 (0.34) CD81PPARG
SCHEMBL10702759 0.87 EP300 (0.34) CD81
SCHEMBL6684085 0.80 IMPDH2 (0.31)
SCHEMBL15535508 0.77 CD81 (0.39) CD81PPARG
SCHEMBL3379812 0.77 CD81 (0.32) CD81PPARG
SCHEMBL14472267 0.76 CD81 (0.36) CD81PPARG
SCHEMBL621263 0.75 CD81 (0.38) CD81PPARG
SCHEMBL137136 0.75 CD81 (0.38) CD81PPARG
SCHEMBL6851328 0.75 CD81 (0.38) CD81PPARG
SCHEMBL6851323 0.75 CD81 (0.38) CD81PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0852745-B1 LIQUID INKS USING A CONTROLLED CRYSTALLINITY ORGANOSOL MINNESOTA MINING & MFG (US) 2002-06-05 EP claimed
EP-0852745-A1 LIQUID INKS USING A CONTROLLED CRYSTALLINITY ORGANOSOL MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-07-15 EP claimed
WO-1997012284-A1 LIQUID INKS USING A CONTROLLED CRYSTALLINITY ORGANOSOL MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-04-03 WO claimed
EP-1205815-B1 Liquid inks comprising surface-treated colorant particles and manufacturing method thereof SAMSUNG ELECTRONICS CO LTD (KR) 2009-12-23 EP disclosed
EP-1327915-B1 Liquid inks comprising stabilizing organosols SAMSUNG ELECTRONICS CO LTD (KR) 2008-12-10 EP disclosed
EP-1229057-B1 Organosol and liquid inks comprising the same SAMSUNG ELECTRONICS CO LTD (KR) 2007-05-23 EP disclosed
US-7098265-B2 Liquid inks comprising a stable organosol SAMSUNG ELECTRONICS CO., LTD. (KR) 2006-08-29 US disclosed
US-20050222407-A1 Method for the preparation of ethylenically unsaturated compounds with lactam-blocked isocyanate groups DSM IP ASSETS B.V. (NL) 2005-10-06 US disclosed
US-20050160938-A1 Liquid inks comprising stabilizing organosols SAMSUNG ELECTRONICS CO., LTD. 2005-07-28 US disclosed
US-6905807-B2 Liquid inks comprising stabilizing organosols SAMSUNG ELECTRONICS CO., LTD. (KR) 2005-06-14 US disclosed
US-20050009952-A1 Liquid inks comprising a stable organosol SAMSUNG ELECTRONICS CO. LTD. 2005-01-13 US disclosed
EP-0852746-B1 LIQUID INKS USING A GEL ORGANOSOL MINNESOTA MINING & MFG (US) 2000-03-15 EP disclosed
EP-0944860-A1 LIQUID INKS USING A GEL ORGANOSOL MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-09-29 EP disclosed
EP-0852745-A1 LIQUID INKS USING A CONTROLLED CRYSTALLINITY ORGANOSOL MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-07-15 EP disclosed
EP-0852746-A1 LIQUID INKS USING A GEL ORGANOSOL MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-07-15 EP disclosed
WO-1998013731-A1 LIQUID INKS USING A GEL ORGANOSOL MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-04-02 WO disclosed
US-5698616-A CONTAINING POLYMERIC STERIC STABILIZER; ADJUSTMENT SOLUBILITY MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-12-16 US disclosed
US-5652282-A Liquid inks using a gel organosol MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-07-29 US disclosed
WO-1997012284-A1 LIQUID INKS USING A CONTROLLED CRYSTALLINITY ORGANOSOL MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-04-03 WO disclosed
WO-1997012285-A1 LIQUID INKS USING A GEL ORGANOSOL MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222407-A1 Method for the preparation of ethylenically unsaturated compounds with lactam-blocked isocyanate groups C9, COASY, TBCB CD81 2738/4885PPARG 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.